Table II.
Characteristic | Low-malignancy group (n=12) | High-malignancy group (n=15) |
---|---|---|
Mean age, years | 42 | 45 |
Age range, years | 33–52 | 28–56 |
Male: female ratio | 1.8:1 | 1.6:1 |
Tumor site | ||
Frontal lobe | 5 | 5 |
Temporal lobe | 4 | 6 |
Parietal lobe | 3 | 4 |
Pathological type | ||
Glioblastoma | 5 | 4 |
Oligodendroglioma | 2 | 4 |
Diffuse astroglioma | 5 | 7 |
Patients were divide into the low-malignancy (WHO grade II; n=12) and high-malignancy groups (WHO grades III–IV; n=15). No statistically significant differences between the two groups were observed in the gender, age, tumor site or pathological type (P>0.05).